These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 30099633)

  • 1. Neoadjuvant therapy for breast cancer treatment: an expert panel recommendation from the Brazilian Society of Breast Surgeons 2018.
    Barbosa C Rocha F; Falcone AB; Buzaid AC; Pimenta JM; Schvartsman G; Frasson AL
    Breast Cancer Res Treat; 2018 Nov; 172(2):265-272. PubMed ID: 30099633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of MRI-evaluated neoadjuvant chemotherapy response on change of surgical recommendation in breast cancer.
    Chen JH; Feig BA; Hsiang DJ; Butler JA; Mehta RS; Bahri S; Nalcioglu O; Su MY
    Ann Surg; 2009 Mar; 249(3):448-54. PubMed ID: 19247033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical management of early stage invasive breast cancer: a practice guideline.
    McCready D; Holloway C; Shelley W; Down N; Robinson P; Sinclair S; Mirsky D; ;
    Can J Surg; 2005 Jun; 48(3):185-94. PubMed ID: 16013621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serbian consensus of neoadjuvant therapy for breast cancer: NeoPULSE.
    Popovic L; Tomasevic Z; Stamatovic L; Markovic I; Matovina-Brko G; Buta M; Golubovic A; Selakovic V; Trifunovic J; Mutrezani Z; Ivanovic N; Nedovic J; Ninkovic S; Filipovic S; Cvetanovic A; Djordjevic N; Karanikolic A; Ivkovic-Kapic T; Vicko F
    J BUON; 2018; 23(2):522-532. PubMed ID: 29745102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant Chemotherapy for Breast Cancer, Is Practice Changing? A Population-Based Review of Current Surgical Trends.
    Graham PJ; Brar MS; Foster T; McCall M; Bouchard-Fortier A; Temple W; Quan ML
    Ann Surg Oncol; 2015 Oct; 22(10):3376-82. PubMed ID: 26202561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refining the Performance of Sentinel Lymph Node Biopsy Post-neoadjuvant Chemotherapy in Patients with Pathologically Proven Pre-treatment Node-positive Breast Cancer: An Update for Clinical Practice.
    El Hage Chehade H; Headon H; Kasem A; Mokbel K
    Anticancer Res; 2016 Apr; 36(4):1461-71. PubMed ID: 27069121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant therapy for breast cancer.
    NIH Consens Statement; 2000 Nov 1-3; 17(4):1-35. PubMed ID: 11512506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How Can We Improve Education of Breast Surgeons Across Europe?
    Kolacinska A
    Chirurgia (Bucur); 2017; 112(4):365-366. PubMed ID: 28862111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tailoring neoadjuvant systemic therapy in breast cancer: "The advent of a personalized approach"-The Breast-Gynecological and Immuno-Oncology International Cancer Conference (BGICC) consensus and recommendations.
    Elghazaly H; Azim HA; Rugo HS; Cameron D; Swain SM; Curigliano G; Harbeck N; Tripathy D; Arun B; Aapro M; Piccart M; Cardoso F; Gligorov J; Elghazawy H; El Saghir NS; Penault-Llorca F; Perez EA; Poortmans P; Abdelaziz H; El-Zawahry HM; Kassem L; Sabry M; Viale G; Al-Sukhun S; Gado N; Leung JWT; Ezz Elarab L; Cardoso MJ; Abdel Karim K; Foheidi M; Elmaadawy MM; Conte P; Selim ASM; Kandil A; Kamal RM; Paltuev RM; Guarneri V; Abulkhair O; Zakaria O; Golshan M; Orecchia R; ElMahdy M; Abdel-Aziz AM; Eldin NB
    Cancer; 2024 Oct; 130(19):3251-3271. PubMed ID: 38985794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast conservation following neoadjuvant therapy for breast cancer in the modern era: Are we losing the opportunity?
    Criscitiello C; Curigliano G; Burstein HJ; Wong S; Esposito A; Viale G; Giuliano M; Veronesi U; Santangelo M; Golshan M
    Eur J Surg Oncol; 2016 Dec; 42(12):1780-1786. PubMed ID: 27825710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of the axilla after neoadjuvant chemotherapy for clinically node positive breast cancer: A nationwide survey study in The Netherlands.
    Vugts G; Maaskant-Braat AJ; de Roos WK; Voogd AC; Nieuwenhuijzen GA
    Eur J Surg Oncol; 2016 Jul; 42(7):956-64. PubMed ID: 27107791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraoperative sentinel node biopsy by one-step nucleic acid amplification (OSNA) avoids axillary lymphadenectomy in women with breast cancer treated with neoadjuvant chemotherapy.
    Navarro-Cecilia J; Dueñas-Rodríguez B; Luque-López C; Ramírez-Expósito MJ; Martínez-Ferrol J; Ruíz-Mateas A; Ureña C; Carrera-González MP; Mayas MD; Martínez-Martos JM
    Eur J Surg Oncol; 2013 Aug; 39(8):873-9. PubMed ID: 23711734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rates of Neoadjuvant Chemotherapy and Oncoplastic Surgery for Breast Cancer Surgery: A French National Survey.
    Clough KB; Acosta-Marín V; Nos C; Alran S; Rouanet P; Garbay JR; Giard S; Verhaeghe JL; Houvenaeghel G; Flipo B; Dauplat J; Dorangeon PH; Classe JM; Rouzier R; Bonnier P
    Ann Surg Oncol; 2015 Oct; 22(11):3504-11. PubMed ID: 25665949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local radiotherapy alone following neoadjuvant chemotherapy and surgery in combined clinical stage II and III breast cancer.
    White R; Dinneen T; Makris A
    Radiat Oncol; 2016 Jul; 11():93. PubMed ID: 27457764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast conservation after neoadjuvant chemotherapy for stage II carcinoma of the breast.
    Schwartz GF; Meltzer AJ; Lucarelli EA; Cantor JP; Curcillo PG
    J Am Coll Surg; 2005 Sep; 201(3):327-34. PubMed ID: 16125064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant therapy for breast cancer has no benefits on overall survival or on the mastectomy rate in routine clinical practice. A population-based study with a median follow-up of 11 years using propensity score matching.
    Le Ray I; Dabakuyo S; Crehange G; Bardou M; Arnould L; Fraisse J; Fumoleau P; Coudert B; Causeret S; Arveux P; Maingon P; Bonnetain F
    Eur J Cancer; 2012 Oct; 48(15):2300-10. PubMed ID: 22513230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of neoadjuvant chemotherapy in the treatment of operable breast cancer.
    Read RL; Flitcroft K; Snook KL; Boyle FM; Spillane AJ
    ANZ J Surg; 2015 May; 85(5):315-20. PubMed ID: 25612239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do MRI and mammography reliably identify candidates for breast conservation after neoadjuvant chemotherapy?
    Jochelson MS; Lampen-Sachar K; Gibbons G; Dang C; Lake D; Morris EA; Morrow M
    Ann Surg Oncol; 2015 May; 22(5):1490-5. PubMed ID: 25777093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging role of taxanes in adjuvant and neoadjuvant therapy for breast cancer: the potential and the questions.
    Goble S; Bear HD
    Surg Clin North Am; 2003 Aug; 83(4):943-71. PubMed ID: 12875604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical Outcomes for Mastectomy Patients Receiving Neoadjuvant Chemotherapy: A Propensity-Matched Analysis.
    Bowen ME; Mone MC; Buys SS; Sheng X; Nelson EW
    Ann Surg; 2017 Mar; 265(3):448-456. PubMed ID: 27280515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.